122 related articles for article (PubMed ID: 36989723)
1. A potential anti-HIV-1 compound, Q308, inhibits HSV-2 infection and replication in vitro and in vivo.
Zhang X; Li A; Li T; Shou Z; Li Y; Qiao X; Zhou R; Zhong X; Li S; Li L
Biomed Pharmacother; 2023 Jun; 162():114595. PubMed ID: 36989723
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
3. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
4. Topical formulations containing Trichilia catigua extract as therapeutic options for a genital and an acyclovir-resistant strain of herpes recurrent infection.
Ribelato EV; Wouk J; Celestino GG; Rodrigues BCD; Darido MLG; Barboza MGL; Botura TJ; de Oliveira MC; de Andrade FG; Lonni AASG; de Mello JCP; da Rocha SPD; Faccin-Galhardi LC
Braz J Microbiol; 2023 Sep; 54(3):1501-1511. PubMed ID: 37338788
[TBL] [Abstract][Full Text] [Related]
5. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.
Yoshida Y; Yamamura J; Sato H; Koyasu M; Obara Y; Sekiguchi H; Kawana T; Shiraki K
J Dermatol Sci; 1996 Dec; 13(3):237-41. PubMed ID: 9023706
[TBL] [Abstract][Full Text] [Related]
7. Guanidine modifications enhance the anti-herpes simplex virus activity of (E,E)-4,6-bis(styryl)-pyrimidine derivatives in vitro and in vivo.
Wang W; Xu C; Zhang J; Wang J; Yu R; Wang D; Yin R; Li W; Jiang T
Br J Pharmacol; 2020 Apr; 177(7):1568-1588. PubMed ID: 31709511
[TBL] [Abstract][Full Text] [Related]
8. 2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.
Strand M; Islam K; Edlund K; Oberg CT; Allard A; Bergström T; Mei YF; Elofsson M; Wadell G
Antimicrob Agents Chemother; 2012 Nov; 56(11):5735-43. PubMed ID: 22908173
[TBL] [Abstract][Full Text] [Related]
9. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
10. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of herpes simplex virus by wedelolactone via targeting viral envelope and cellular TBK1/IRF3 and SOCS1/STAT3 pathways.
Wang Z; Yan H; He F; Wang J; Zhang Y; Sun L; Hao C; Wang W
Int J Antimicrob Agents; 2023 Dec; 62(6):107000. PubMed ID: 37838148
[TBL] [Abstract][Full Text] [Related]
12. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
[TBL] [Abstract][Full Text] [Related]
13. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.
Kesharwani A; Polachira SK; Nair R; Agarwal A; Mishra NN; Gupta SK
BMC Complement Altern Med; 2017 Feb; 17(1):110. PubMed ID: 28196487
[TBL] [Abstract][Full Text] [Related]
14. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.
Wang A; Chen F; Wang Y; Shen M; Xu Y; Hu J; Wang S; Geng F; Wang C; Ran X; Su Y; Cheng T; Wang J
J Virol; 2013 Mar; 87(5):2835-45. PubMed ID: 23269800
[TBL] [Abstract][Full Text] [Related]
16. The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications.
Gordts SC; Férir G; D'huys T; Petrova MI; Lebeer S; Snoeck R; Andrei G; Schols D
PLoS One; 2015; 10(7):e0131219. PubMed ID: 26132818
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of 1,4-disubstituted-1,2,3-triazoles against HSV-1 in vitro.
Viegas DJ; da Silva VD; Buarque CD; Bloom DC; Abreu PA
Antivir Ther; 2020; 25(8):399-410. PubMed ID: 33705354
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Endogenous HIV-1 Reactivation by Endocervical Epithelial Cells.
Gornalusse GG; Valdez R; Fenkart G; Vojtech L; Fleming LM; Pandey U; Hughes SM; Levy CN; Dela Cruz EJ; Calienes FL; Kirby AC; Fialkow MF; Lentz GM; Wagoner J; Jing L; Koelle DM; Polyak SJ; Fredricks DN; McElrath MJ; Wald A; Hladik F
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051273
[TBL] [Abstract][Full Text] [Related]
19. HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesviruses.
Yan Z; Bryant KF; Gregory SM; Angelova M; Dreyfus DH; Zhao XZ; Coen DM; Burke TR; Knipe DM
mBio; 2014 Jul; 5(4):e01318-14. PubMed ID: 24987091
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus resistance to acyclovir: clinical relevance.
Pottage JC; Kessler HA
Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
